Search

everythinglearnresearchcommunity

for

Search:↓

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Finasteride, a drug used for anti-hyperplasia, can be effectively delivered in the form of matrix tablets.

Hair plucking quickly increases antizyme, reducing a specific enzyme activity in rats.

The new nanofiber improves wound healing by releasing growth factors, reducing inflammation, and helping skin regeneration.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Bupropion SR may help treat trichotillomania.

TM-β-CD improves finasteride's solubility and delivery, while β-CD offers better long-term release.

A new method using hydrogels and microneedle patches improves minoxidil delivery for better hair growth.

CRH can cause hair loss by promoting cell death in hair growth cells.

The hydrogel effectively treats hair loss using light to release nitric oxide.

Ganoderma lucidum extract may help treat stress-related hair loss.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

Ferroportin in macrophages is crucial for hair growth and skin healing by managing iron distribution.

The CRH/CRH-R1 system might be involved in causing lichen planus.

The new controlled release PRP therapy shows promise for hair growth in women.

Lipid nanoparticles show promise for delivering alopecia treatments to the skin.

PPCM microspheres can effectively release finasteride over 42 days.

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

Constant-release melatonin reduces SOX21 gene expression in goats during the hair follicle resting phase.

Finasteride sustained-release tablets are stable.

Platelet-released growth factors can treat hair loss by activating hair follicle stem cells, blocking certain pathways, and controlling inflammation and fibrosis.

The skin produces and responds to thyroid-stimulating hormone, which is controlled by other thyroid-related hormones.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.